Serum leptin levels in patients with liver cirrhosis and chronic viral hepatitis

被引:42
|
作者
Comlekci, A [1 ]
Akpinar, H
Yesil, S
Okan, I
Ellidokuz, E
Okan, A
Ersoz, G
Tankurt, E
Batur, Y
机构
[1] Dokuz Eylul Univ, Sch Med, Dept Internal Med, Div Endocrinol, TR-35340 Izmir, Turkey
[2] Ege Univ, Sch Med, Div Gastroenterol, Izmir, Turkey
[3] Dokuz Eylul Univ, Sch Med, Dept Internal Med, Div Gastroenterol, TR-35340 Izmir, Turkey
关键词
body composition; chronic viral hepatitis; insulin resistance; leptin; liver cirrhosis;
D O I
10.1080/00365520310003877
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The aim of the present study was to investigate serum leptin levels in relation to anthropometric features in patients with liver cirrhosis (LC) and chronic viral hepatitis (CVH), and to determine the effect of the severity and aetiology of the LC on serum leptin levels. Methods: Forty-nine patients with LC, 32 patients with CVH and 69 control subjects were age, body mass index (BMI) and sex-matched and included in the study. Plasma glucose, serum leptin and insulin levels were determined. Insulin resistance was assessed using homoeostasis model assessment (HOMA). Body composition was estimated by skinfold thickness. Results: Female patients with Child-A LC had higher levels of leptin, and female and male patients with Child-A LC had higher absolute leptin (leptin/BFM) levels compared to patients with Child-C LC and control subjects. Serum leptin levels of the patients with alcohol LC were higher than the control subjects, but the absolute leptin levels were comparable. When alcoholic and post-viral hepatitis cirrhotic patients were compared with each other on an aetiologic basis, there was no significant difference between them in leptin and absolute leptin levels. There were significant correlations between leptin and BMI, body fat percentage (BFP), BFM (body fat mass) in all three groups in both sexes. Conclusions: These data suggest that the physiologic correlations among serum leptin level, sex, BMI and BFM were well preserved in patients with chronic liver disease. Patients with alcohol LC had higher leptin levels. In early stages of liver disease, leptin levels and absolute leptin levels are higher than in normal subjects. However, in advanced stages of the disease the significant decline in leptin levels and similar levels of leptin expressed in relation to BFM compared to control subjects predominantly represent the expression of fat mass.
引用
收藏
页码:779 / 786
页数:8
相关论文
共 50 条
  • [31] Plasma progastrin and leptin in type B and C viral hepatitis and liver cirrhosis
    Konturek, SJ
    Gonciarz, Z
    Bielanski, W
    Gonciarz, M
    Mazur, W
    Mularczyk, A
    Rehfeld, JE
    GASTROENTEROLOGY, 2002, 122 (04) : A306 - A306
  • [32] Serum viral load is not the major determinant of hepatocellular carcinoma risk in chronic hepatitis B patients with compensated liver cirrhosis
    Tseng, Tai-Chung
    Liu, Chun-Jen
    Yang, Wan-Ting
    Yang, Hung-Chih
    Chen, Chi-Ling
    Su, Tung-Hung
    Kao, Jia-Horng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 22 - 23
  • [33] Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis
    Cicognani, C
    Malavolti, M
    MorselliLabate, AM
    Zamboni, L
    Sama, C
    Barbara, L
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (07) : 792 - 796
  • [34] USEFULNESS OF SERUM MARKERS FOR PREDICTING LIVER CIRRHOSIS IN PATIENTS WITH CHRONIC HEPATITIS B
    Lee, Kwang Gyun
    Seo, Yeon Seok
    An, Hyonggin
    Jung, Eun Suk
    Keum, Bora
    Kim, Yong Sik
    Yim, Hyung Joon
    Jeen, Yoon Tae
    Chun, Hoon Jai
    Kim, Chang Duck
    Ryu, Ho Song
    Um, Soon Ho
    HEPATOLOGY, 2008, 48 (04) : 684A - 684A
  • [35] HEPATOCELLULAR CARCINOMA AMONG PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS OF ALCOHOLIC ETIOLOGY
    Bygaeva, T. T.
    Ivanov, P. M.
    Sleptsova, S. S.
    YAKUT MEDICAL JOURNAL, 2013, (01): : 52 - 59
  • [36] The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis
    Kuper, H
    Ye, WM
    Broomé, U
    Romelsjö, A
    Mucci, LA
    Ekbom, A
    Adami, HO
    Trichopoulos, D
    Nyrén, O
    HEPATOLOGY, 2001, 34 (04) : 714 - 718
  • [37] Effect of Antiviral Therapy on Cardiohemodynamic Indicators in Patients with Chronic Viral Hepatitis and Liver Cirrhosis
    Chistyakova, Marina V.
    Govorin, Anatoly V.
    Radaeva, Eugene V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (06) : 681 - 684
  • [38] Thrombopoietin levels in thrombocytopenic patients with liver cirrhosis and chronic hepatitis C.
    Espanol, I
    Hernandez, A
    Remacha, AF
    Ayats, R
    PujolMoix, N
    BLOOD, 1997, 90 (10) : 3081 - 3081
  • [39] COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis
    Zachou, Kalliopi
    Gabeta, Stella
    Shums, Zakera
    Gatselis, Nikolaos K.
    Koukoulis, George K.
    Norman, Gary L.
    Dalekos, George N.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 38 : 83 - 88
  • [40] Serum levels of IgA inform on the transcriptomic architecture of the liver and predict hepatocellular carcinoma in chronic viral hepatitis patients
    Van Renne, Nicolaas
    Van Hees, Stijn
    Cuypers, Bart
    d'Almeida, Arno Furquim
    Vanderlinden, Axelle
    Meysman, Pieter
    Feld, Jordan J.
    Sangro, Paloma
    Bourgeois, Stefan
    Sprengers, Dirk
    Robaeys, Geert
    Vonghia, Luisa
    Michielsen, Peter
    Francque, Sven
    Sangro, Bruno
    Cain, Owen
    Elsharkawy, Ahmed M.
    de Man, Robert A.
    Boonstra, Andre
    Janssen, Harry
    Driessen, Ann
    Laukens, Kris
    Vanwolleghem, Thomas
    JOURNAL OF HEPATOLOGY, 2024, 80 : S730 - S731